dr. forster discusses the atlantis study in small-cell lung cancer
Published 6 years ago • 325 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
1:28
dr. forster on recent data with lurbinectedin in sclc
-
1:54
dr. forster on next steps with lurbinectedin in sclc
-
3:00
small-cell lung cancer: future directions in care
-
5:27
asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial
-
2:17
small cell lung cancer: future directions in care
-
2:01
findings from atlantis: lurbinectedin/doxorubicin vs topotecan or cav in sclc
-
1:50
small cell lung cancer: interpreting data from impower133
-
1:33
dr. chaft on the rise of immunotherapy in lung cancer
-
2:00
dr. west on lurbinectedin in sclc
-
6:56
advances in small cell lung cancer research | hope for the future
-
1:24:26
assessing the impact of therapeutic advances in sclc
-
1:33
dr. chaft on the emergence of immunotherapy in stage iv lung cancer
-
1:05
dr. sabari discusses role of immunotherapy in sclc
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
27:08
immunotherapy advances in small cell lung cancer
-
29:46
lung cancer and immunotherapy with dr. patrick forde and oswald peterson
-
56:45
dr. triparna sen: small cell lung cancer research
-
6:08
asco20 - new research in non-small cell lung cancer
-
1:54
dr. perez-soler on the future of lung cancer therapies